Canada · Health Canada Drug Product Database
NIMENRIX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 88773
- DIN
- 02402904
- Form
- Kit, Powder For Solution
- Company as listed by source
- PFIZER CANADA ULC
- Source status
- Marketed (2017-05-17)
- Source last updated
- 2025-08-15
Source-listed ingredients
- MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A — 5 MCG — per 0.5 ML
- MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C — 5 MCG — per 0.5 ML
- MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135 — 5 MCG — per 0.5 ML
- MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y — 5 MCG — per 0.5 ML
- TETANUS TOXOID — 44 MCG — per 0.5 ML
These values do not establish equivalence or a dose recommendation.
Packages
- 0.5ml/10x0.5ml
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →